All In Biotech

Drug Trial Radar · NCT06990269

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

A Phase 2, Randomized, Masked, Placebo-Controlled Study of Subcutaneously Administered ADX-038 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 240 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

240

Planned (sponsor's estimate)

Start

Nov 10, 2025

Primary completion

Feb 28, 2030

Study completion Aug 30, 2030

Sponsor

Lead sponsor
ADARx Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
May 25, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 2 study is designed to assess the efficacy of ADX-038 compared with placebo in participants with GA secondary to AMD. Safety, pharmacokinetics (PK), and pharmacodynamics (PD) will also be assessed.

Conditions

  • Geographic Atrophy Secondary to Age-related Macular Degeneration

Interventions

  • ADX-038Drug

    siRNA duplex oligonucleotide

  • PlaceboDrug

    Saline

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluate the effect of ADX-038 on the preservation of the EZ layerTime frame: 12 months

Locations

83 sites in 12 countries. Site status is shown where the registry gives one.

  • ADARx Clinical Site

    Gilbert, Arizona · Recruiting

  • ADARx Clinical Site

    Phoenix, Arizona · Recruiting

  • ADARx Clinical Site

    Bakersfield, California · Recruiting

  • ADARx Clinical Site

    Beverly Hills, California · Recruiting

  • ADARx Clinical Site

    Huntington Beach, California · Recruiting

  • ADARx Clinical Site

    Poway, California · Recruiting

  • ADARx Clinical Site

    Riverside, California · Recruiting

  • ADARx Clinical Site

    Walnut Creek, California · Recruiting

  • ADARx Clinical Site

    Orlando, Florida · Recruiting

  • ADARx Clinical Site

    Wildwood, Florida · Recruiting

  • ADARx Clinical Site

    Hagerstown, Maryland · Recruiting

  • ADARx Clinical Site

    Reno, Nevada · Recruiting

  • ADARx Clinical Site

    Erie, Pennsylvania · Withdrawn

  • ADARx Clinical Site

    Austin, Texas · Recruiting

  • ADARx Clinical Site

    Bellaire, Texas · Recruiting

  • ADARx Clinical Site

    Dallas, Texas · Recruiting

  • ADARx Clinical Site

    McAllen, Texas · Recruiting

  • ADARx Clinical Site

    Round Rock, Texas · Recruiting

  • ADARx Clinical Site

    San Antonio, Texas · Recruiting

  • ADARx Clinical Site

    The Woodlands, Texas · Recruiting

  • ADARx Clinical Site

    St. George, Utah · Recruiting

  • ADARx Clinical Site

    Malvern, Australia · Recruiting

  • ADARx Clinical Site

    Sydney, Australia · Recruiting

  • ADARx Clinical Site

    Albury, New South Wales, Australia · Recruiting

  • ADARx Clinical Site

    Hurstville, New South Wales, Australia · Recruiting

  • ADARx Clinical Site

    Parramatta, New South Wales, Australia · Recruiting

  • ADARx Clinical Site

    Sutherland, New South Wales, Australia · Recruiting

  • ADARx Clinical Site

    Sydney, New South Wales, Australia · Recruiting

  • ADARx Clinical Site

    East Melbourne, Victoria, Australia · Recruiting

  • ADARx Clinical Site

    Rowville, Victoria, Australia · Recruiting

  • ADARx Clinical Site

    Vienna, Austria · Not yet recruiting

  • ADARx Clinical Site

    Vienna, Austria · Not yet recruiting

  • ADARx Clinical Site

    Graz, Styria, Austria · Not yet recruiting

  • ADARx Clinical Site

    Innsbruck, Tyrol, Austria · Not yet recruiting

  • ADARx Clinical Site

    Edmonton, Alberta, Canada · Not yet recruiting

  • ADARx Clinical Site

    Vancouver, British Columbia, Canada · Recruiting

  • ADARx Clinical Site

    Vancouver, British Columbia, Canada · Recruiting

  • ADARx Clinical Site

    London, Ontario, Canada · Not yet recruiting

  • ADARx Clinical Site

    Ottawa, Ontario, Canada · Recruiting

  • ADARx Clinical Site

    Ottawa, Ontario, Canada · Recruiting

Showing 40 of 83 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.